The "IHC Extended Panel >10 Markers" test, available at DNA Labs UAE, is a comprehensive immunohistochemistry (IHC) analysis designed to examine more than 10 specific markers in a tissue sample. This advanced diagnostic tool is crucial for identifying the presence and expression levels of various proteins that can provide valuable insights into the nature of diseases, particularly in the context of cancer. By targeting a wide range of markers, this extended panel enhances the precision of diagnosis, prognosis, and helps in determining the most effective treatment strategies.
The cost of the "IHC Extended Panel >10 Markers" test at DNA Labs UAE is set at 1950 AED. This investment in health diagnosis enables healthcare professionals to tailor treatment plans more accurately to the individual's condition, potentially leading to better outcomes. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring high-quality and reliable test results. This test is an invaluable resource for patients and doctors alike, providing critical information that supports informed decision-making in complex clinical scenarios.
The "IHC Up to 5 Markers Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to analyze up to five immunohistochemistry (IHC) markers. This test plays a crucial role in the field of pathology and oncology, as it helps in the detailed examination of tissues to identify specific cellular components, proteins, and markers that are pivotal in diagnosing various diseases, including different types of cancers. By utilizing antibodies to detect these markers in tissue samples, the test provides valuable information on the presence, absence, or quantity of these markers, aiding in the determination of the disease type and its progression. The cost of the IHC Up to 5 Markers Test at DNA Labs UAE is set at 1950 AED, reflecting the sophisticated technology and expertise required to conduct this intricate analysis. This test is a vital tool for healthcare professionals in making accurate diagnoses and developing effective treatment plans for patients.
The "Large Biopsy 8 Test" is a comprehensive diagnostic procedure offered by DNA Labs UAE, designed to analyze large biopsy samples for a wide array of medical conditions. This advanced test plays a critical role in the detection, diagnosis, and management of diseases by examining tissue samples under a microscopic lens to identify cellular abnormalities, infections, or cancerous developments. Priced at 1950 AED, the test offers a cost-effective solution for patients seeking in-depth analysis and insights into their health conditions. DNA Labs UAE utilizes state-of-the-art technology and expertise to ensure accurate, reliable, and timely results, aiding healthcare professionals in devising effective treatment plans.
The "Periodontal Multiplex Detection and Differentiation Test" is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to identify and differentiate between four major bacteria associated with periodontal diseases: Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, and Fusobacterium nucleatum. This qualitative RNA detection test utilizes advanced molecular techniques to accurately identify the presence of these pathogens in a patient's sample, enabling healthcare professionals to tailor more effective treatment strategies for periodontal conditions.
Periodontal diseases, which affect the tissues supporting the teeth, can lead to severe dental issues and even tooth loss if not properly managed. The bacteria targeted by this test are known to be key contributors to the development and progression of periodontal disease, making their identification crucial for effective management and treatment.
The test is priced at 1950 AED and is conducted at DNA Labs UAE, a leading facility known for its state-of-the-art diagnostic services. By providing precise and timely detection of these periodontal pathogens, the test plays a vital role in the early intervention and management of periodontal diseases, ultimately contributing to better oral health outcomes for patients.
The "Periodontal Multiplex Detection and Differentiation Porphyromonas gulae, Treponema denticola, Tannerella forsythia, and Fusobacterium nucleatum RNA Detection Qualitative Test" is a specialized diagnostic procedure conducted at DNA Labs UAE. Priced at 2210 AED, this test is designed to accurately identify and differentiate between the RNA of four major bacteria known to cause periodontal disease: Porphyromonas gulae, Treponema denticola, Tannerella forsythia, and Fusobacterium nucleatum. Utilizing advanced molecular techniques, this qualitative test enables precise detection of these pathogens, offering crucial insights for the effective management and treatment of periodontal conditions. The test's multiplex approach not only ensures a comprehensive analysis but also aids in the early diagnosis of periodontal diseases, facilitating targeted interventions and improved patient outcomes.
This test is a sophisticated diagnostic tool designed to identify and differentiate between the RNA of four key bacteria known to cause periodontal disease: Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, and Tannerella forsythia. Utilizing advanced RNA detection techniques, this qualitative test is capable of pinpointing the specific bacteria present in the oral cavity, thereby enabling healthcare professionals to tailor more effective treatment strategies for periodontal disease.
Conducted at DNA Labs UAE, a leading facility in genetic and microbiological testing, this test offers a rapid and accurate assessment of the bacterial composition in periodontal pockets. With a cost of 2210 AED, it represents a significant investment in oral health, providing critical insights that can guide the management of periodontal diseases, from prevention through to advanced treatment modalities. The utilization of this test underscores the importance of precision medicine in dentistry, offering a personalized approach to periodontal care based on the specific pathogens involved.
The "Shrimp TSV (Taura Syndrome Virus), YHV (Yellow Head Virus), and IMNV (Infectious Myonecrosis Virus) RNA Virus Multiplex Detection and Differentiation RNA Detection Qualitative Test" is a sophisticated diagnostic assay conducted by DNA Labs UAE. Priced at 2210 AED, this test is designed to simultaneously detect and differentiate between three of the most significant viral pathogens affecting shrimp populations globally: TSV, YHV, and IMNV. Utilizing cutting-edge RNA detection methodologies, this multiplex test offers a qualitative analysis, determining the presence or absence of these viruses in shrimp samples without quantifying the viral load. The ability to detect and differentiate between these viruses in a single assay enhances the efficiency of diagnostics, significantly aiding in the management and control of these diseases in aquaculture operations. Conducted in a state-of-the-art laboratory setting, this test is crucial for shrimp farmers and aquaculture health professionals aiming to maintain healthy stock and mitigate the economic impacts of these viral pathogens.
The "TORCH Multiplex Detection and Differentiation RNA Detection Qualitative Test" is an advanced diagnostic procedure available at DNA Labs UAE, designed to simultaneously detect and differentiate infections caused by the TORCH complex of viruses. This complex includes Toxoplasma gondii (TOXO), Rubella virus (RUB), Cytomegalovirus (CMV), and Herpes Simplex virus (HSV) 1 and 2. These pathogens are of particular concern in pregnant women, as they can lead to severe congenital infections in the fetus, leading to birth defects or miscarriage.
Utilizing state-of-the-art RNA detection technologies, this qualitative test offers a high degree of sensitivity and specificity, ensuring accurate identification of the viral RNA without the need for multiple tests. This is particularly crucial for early diagnosis and management of infections to mitigate potential risks to both pregnant women and their unborn children.
Performed at DNA Labs UAE, a leading facility known for its advanced diagnostic capabilities and stringent quality control measures, the test assures patients of reliable results. The cost of the test is set at 2210 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed.
This test is an invaluable tool for healthcare providers, offering critical insights into infections by the TORCH viruses, thereby facilitating timely and appropriate interventions to protect maternal and fetal health.
Alpha Amino Adipic Aciduria, also known as Alpha-Aminoadipic Aciduria, is a rare metabolic condition characterized by the excessive excretion of alpha-aminoadipic acid in urine. This condition often suggests a disturbance in the lysine degradation pathway, which can have implications for an individual's health, necessitating accurate diagnosis and monitoring.
The Alpha Amino Adipic Aciduria Test is a specialized diagnostic procedure aimed at detecting abnormal levels of alpha-aminoadipic acid in the urine, which can help in diagnosing this rare metabolic disorder. This test is crucial for individuals who exhibit symptoms suggestive of metabolic disorders or for those with a family history of such conditions, enabling early intervention and management.
At DNA Labs UAE, the test is meticulously conducted using advanced techniques to ensure accuracy and reliability. The cost of the Alpha Amino Adipic Aciduria Test is 2210 AED. DNA Labs UAE is equipped with state-of-the-art facilities and staffed by experienced professionals, ensuring that patients receive the highest standard of care and precise test results. This test is an important tool in the diagnostic process, contributing to a better understanding of the patient's condition and guiding the appropriate treatment plans.
The Acetylcholine Receptor (AChR) Blocking Antibody Test is a specialized diagnostic procedure aimed at detecting antibodies that may interfere with the normal functioning of acetylcholine receptors. These receptors are crucial for muscle contraction and play a significant role in various neuromuscular junctions. The presence of blocking antibodies can lead to conditions such as Myasthenia Gravis, an autoimmune disorder characterized by weakness and fatigue of skeletal muscles. This test is particularly useful for diagnosing and managing this condition, offering insights into the severity of the immune response and guiding treatment strategies.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic services and precise testing methodologies. The cost of the AChR Blocking Antibody Test is set at 2000 AED. This investment covers the sophisticated techniques and expertise required to accurately detect and quantify the presence of these specific antibodies. Patients or healthcare providers looking for comprehensive and reliable diagnostic services in the region can consider DNA Labs UAE as a trusted partner in healthcare management, especially for conditions related to neuromuscular disorders.
